Citius Oncology (CTOR) Stock Chart & Stock Price History $0.88 -0.01 (-1.63%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$0.87 -0.01 (-0.86%) As of 06:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Citius Oncology Stock Price Performance The Citius Oncology (CTOR) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 23.87%. In the past month, the stock has increased 32.65%, reflecting recent market activity. As of the latest close, Citius Oncology traded at $0.88 with a market cap of $62.64 million and volume of 56,123 shares. Receive CTOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.32%1 Month Performance+32.65%3 Month Performance-25.17%Year-To-Date Performance-23.87% CTOR Stock Chart for Thursday, May, 22, 2025 CTOR Chart by TradingView Citius Oncology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$0.89$0.88-1.63%$0.94$0.8756,123 shs$62.64 million05/20/2025$0.91$0.89-2.20%$0.91$0.8615,994 shs$63.68 million05/19/2025$0.92$0.91-0.55%$0.94$0.8954,836 shs$65.11 million05/16/2025$0.89$0.92+3.38%$0.92$0.8843,465 shs$65.47 million05/15/2025$0.89$0.89-0.58%$0.92$0.8521,577 shs$63.33 million05/14/2025$0.92$0.89-2.83%$0.92$0.8671,189 shs$63.70 million05/13/2025$0.89$0.92+2.59%$0.94$0.85103,750 shs$65.56 million05/12/2025$0.88$0.89+1.49%$0.95$0.83137,822 shs$63.90 million05/09/2025$0.85$0.88+4.14%$0.92$0.8474,203 shs$62.97 million05/08/2025$0.85$0.85-0.24%$0.94$0.8248,474 shs$60.46 million Get the Latest News and Ratings for CTOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$0.87$0.85-2.51%$0.90$0.8232,131 shs$60.61 million05/06/2025$0.88$0.87-1.27%$0.91$0.8427,004 shs$62.16 million05/05/2025$0.93$0.88-4.86%$0.95$0.8431,168 shs$62.97 million05/02/2025$0.89$0.93+3.93%$0.98$0.91102,364 shs$66.19 million05/01/2025$0.87$0.89+2.51%$0.89$0.8275,728 shs$63.68 million04/30/2025$0.89$0.87-2.89%$0.89$0.8158,119 shs$62.12 million04/29/2025$0.70$0.89+27.70%$0.89$0.69191,515 shs$63.97 million04/28/2025$0.73$0.70-3.96%$0.73$0.6942,547 shs$50.09 million04/25/2025$0.64$0.73+13.73%$0.74$0.66179,674 shs$52.16 million04/24/2025$0.67$0.64-4.33%$0.70$0.6454,239 shs$45.87 million04/23/2025$0.66$0.67+1.52%$0.68$0.6425,723 shs$47.94 million04/22/2025$0.62$0.66+6.28%$0.67$0.6344,432 shs$47.22 million04/21/2025$0.67$0.62-7.58%$0.67$0.6265,168 shs$44.43 million Related Companies Atea Pharmaceuticals Stock Chart Neurogene Stock Chart Aerovate Therapeutics Stock Chart Gossamer Bio Stock Chart Alumis Stock Chart Foghorn Therapeutics Stock Chart Candel Therapeutics Stock Chart Astria Therapeutics Stock Chart Acelyrin Stock Chart Aardvark Therapeutics Stock Chart Receive CTOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTOR) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTOR Stock Free CTOR Stock Alerts